Per Sandin
Papers
1
Total Citations
63
H-Index
1
About
Per Sandin is a distinguished researcher in drug discovery and development, with a primary focus on early in vitro metabolite identification and the evolution of pharmaceutical screening technologies. His most cited work, the 2006 paper "Introduction to early in vitro identification of metabolites of new chemical entities in drug discovery and development," has garnered 63 citations and stands as a key contribution to the field. In this seminal piece, Sandin critically examines how the advent of combinatorial chemistry and robotics for high throughput screening has fundamentally transformed drug discovery over the past decade and a half. He highlights the shift from testing fewer compounds in animal or organ models to more efficient, automated in vitro approaches, while emphasizing the pivotal role of advanced analytical techniques, particularly liquid chromatography, in enabling rapid metabolite identification. Sandin’s work provides a comprehensive framework for understanding how these technological innovations accelerate the early stages of drug development, improving both safety and efficacy assessments. His research continues to inform best practices in pharmaceutical R&D, making him a valuable voice for students and professionals navigating the modern landscape of drug discovery.
Research Focus
Key Achievements
Top Papers
- 1